PubMed Health⌕ Search

Biomedical subjects

P Kruck

Publications and source records attributed to P Kruck.

10 recordsLinked to original sources

[Outcome quality in oncologic rehabilitation. Viewpoint of the Professional Committee of Rehabilitation, After-Care and Social Medicine of the German Cancer Society].

The article is concerned with the basic ideas of outcome quality within the field of oncological rehabilitation and expresses the position which is held by the Section for Rehabilitation, Aftercare and Social Medicine within the German Cancer Society. The authors explicitly express the necessity of rehabilitation-specific goals and corresponding outcome criteria as opposed to the goals and criteria of acute oncological treatment. In the formulation of goals and criteria, the medical-somatic, occupational-rehabilitative, social and psychological levels are considered. The consequences which arise from these outcome criteria with regard to the rehabilitative health care system for cancer patients are discussed.

Aftercare↗

[Process quality in oncologic rehabilitation. Viewpoint of the Professional Committee of Rehabilitation, After-care and Social Medicine of the German Cancer Society].

The article concerns itself with the issue of process quality in inpatient institutions for oncological rehabilitation and expresses the viewpoint of the German Cancer Society's Section for Rehabilitation, Aftercare and Social Medicine (ARNS). Standards for the organization of patients' access to the rehabilitation clinic, for the design of oncological-rehabilitational diagnostics, for the formation of therapeutic strategies and the rehabilitative services offered will be described.

Aftercare↗

[Structural quality of oncologic rehabilitation. Viewpoint of the Professional Committee of Rehabilitation, After-care and Social Medicine of the German Cancer Society].

The article discusses the structural requirements on inpatient institutions for oncological rehabilitation and expresses the position of the German Cancer Society's Section for Rehabilitation, Aftercare and Social Medicine (ARNS). Standards are formulated concerning spatial conditions, technical equipment, personnel (number, professions, qualification) and networking conditions with regard to all cancer diagnoses. These standards are also discussed with regard to various specific cancer diagnoses such as, for example, breast cancer, gastrointestinal tumours, lung tumours and brain tumours, as well as with regard to patients in specific treatment measures such as bone marrow and stem cell transplantation.

Aftercare↗

[Value of tumor-associated antigens CA 72-4 vs. CEA and CA 19-9 in the follow-up after stomach cancer].

OBJECTIVE: To compare the value of tumour markers CA-72-4 and CA 19-9 and the cardioembryonic antigen (CEA) in the follow-up of patients after potentially curative surgery of gastric carcinoma. PATIENTS AND METHODS: CA 72-4, CA 19-9 and CEA were measured prospectively in 279 patients 1-36 months after potentially curative primary surgery for histologically proven gastric carcinoma. Evaluation was by "receiver-operating-characteristics" (ROC) curves using "believe the positive" rules as well as by linear combinations. RESULTS: Recurrences were found in 54 patients. CA 72-4 (by radioimmunoassay) was the most sensitive single test (sensitivity 43%, specificity 95%). Radioimmunological and enzyme-immunological tests of CA 79-4 correlated well (r = 0.8). The various values, obtained by certain test kits, when newly calculated for the purpose of after-care, differed markedly from upper limits reported by the manufacturers. Measurement of both CA 72-4 and CA 19-9 increased the sensitivity to 54%. INTERPRETATION: Special levels of CA 72-4 and CA 19-9 have been identified which are of value in the follow-up of patients after operation for gastric carcinoma. Single measurements of CA 74-2 are as a rule preferable to those of CA 19-9 or of both CA 11-9 and CEA. In fact, CEA should be measured only in exceptional circumstances. But combined measurements of CA 72-4 and CA 19-9 increase sensitivity and prognostic value of the results.

Adenocarcinoma↗

[Chronic destructive non-suppurating cholangitis].

Initially liver morphology of chronic destructive non-suppurative cholangitis (CDNC) is rather atypical. Therefore, early morphological diagnosis is difficult. First symptoms are severe pruritus and an increase of IgM, AP and gamma-GT. Own investigation of 101 CDNC patients showed that antimitochondrial antibodies (AMA) are generally later present than the increase of the a/m enzymes. Also remarkable is the fact that among 101 patients are 13 men generally observed during the last 3 years. The most difficult problem is the treatment of CDNC. Here we have to differentiate between symptomatic basic treatment and so-called specific treatment. As basic treatment, ammonia-reducing amino acids, phenobarbital and finally cholestyramine are administered in order to diminish the severe pruritus. The diet must be rich on pectine. Lactulose and bifidum milk improve the diminished detoxication function of the liver. As specific treatment prednisolone and/or azathioprin have disappointed. D-penicillamine can influence CDNC at least temporarily. Because of the frequent side-effects D-penicillamine should be administered only in low doses (100-200 mg daily together with 300 mg vitaminee B6). Until not it is uncertain if the extremely bad prognosis of CDNC can be improved by medical treatment of its early stages.

Aged↗